Retinal prosthesis system that utilizes electrical stimulation to partially restore sight in patients blinded by outer retinal degeneration
There’s no risk. Start your trial today to see profiles of Second Sight Medical (NASDAQ:EYES) plus 5230 other startups.
Start Free 7 Day Trial Now